Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction – A multicenter study

OBJECTIVE: To study the prognostic value of soluble Suppression of Tumorigenicity-2 (sST2) in heart failure patients with reduced ejection fraction (HFrEF). METHODS: In this prospective, observational, multicenter study, patients with heart failure (HF) and left ventricular ejection fraction (LVEF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahuleyan, C.G., Alummoottil, George Koshy, Abdullakutty, Jabir, Lordson, A. Jinbert, Babu, Shifas, Krishnakumar, V.V., Pillai, Anand M., Abraham, George, Dilip, M.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097172/
https://www.ncbi.nlm.nih.gov/pubmed/30122243
http://dx.doi.org/10.1016/j.ihj.2017.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097172/
https://www.ncbi.nlm.nih.gov/pubmed/30122243
http://dx.doi.org/10.1016/j.ihj.2017.09.010

Ejemplares similares